AIAI-Designed Universal Coronavirus Vaccine Clears Its First Human Trial
Cambridge's AI-powered DIOSynVax platform designed a broad-protection coronavirus vaccine entirely by computer — and on June 5, 2026 it was reported safe in a first human trial.
Dr. Nova Chen★Jun 6, 2026★5 min read
